[The Properdin Problem]

Overview

Journal Blut

Specialty Hematology

Date 1958 Nov 1

PMID 13607586

Citations 1

Authors

H E SCHULTZE

G SCHWICK

Affiliations

Soon will be listed here.

Citing Articles

[Methodical and clinical research on the properdin system. II. Research on the behavior of the serum properdin and the C'3 components after gynecological operations].

Schumacher G, EL HABASH E, SCHLUMBERGER H Arch Gynakol. 1961; 196:167-79.

PMID: 13748953 DOI: 10.1007/BF00669448.

References

ROTTINO A, Levy A . Serum-properdin levels in patients with Hodgkin's disease and carcinoma. Cancer. 1957; 10(5):877-83. DOI: 10.1002/1097-0142(195709/10)10:5<877::aid-cncr2820100504>3.0.co;2-5. View

Landy M, PILLEMER L . Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides. J Exp Med. 1956; 104(3):383-409. PMC: 2136568. DOI: 10.1084/jem.104.3.383. View

PILLEMER L, Blum L, Lepow I, Ross O, Todd E, Wardlaw A . The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954; 120(3112):279-85. DOI: 10.1126/science.120.3112.279. View

PILLEMER L, Ross O . Alterations in serum properdin levels following injection of Zymosan. Science. 1955; 121(3151):732-3. DOI: 10.1126/science.121.3151.732. View

Fritzsche W, Martin H . [Properdin and hemolysis; heparin inhibition of erythrocyte hemolysis in patients with paroxysmal nocturnal hemoglobinuria]. Klin Wochenschr. 1957; 35(23):1166-8. DOI: 10.1007/BF01497705. View

SCHEIFFARTH F, FRENGER W, Gotz H . [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin]. Klin Wochenschr. 1958; 36(8):367-9. DOI: 10.1007/BF01477087. View

PILLEMER L, Landy M, Shear M . The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides. J Exp Med. 1957; 106(1):99-110. PMC: 2136727. DOI: 10.1084/jem.106.1.99. View

PILLEMER L, SCHOENBERG M, Blum L, WURZ L . Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955; 122(3169):545-9. DOI: 10.1126/science.122.3169.545. View

PILLEMER L, Blum L, Lepow I, WURZ L, Todd E . The properdin system and immunity. III. The zymosan assay of properdin. J Exp Med. 1956; 103(1):1-13. PMC: 2136566. DOI: 10.1084/jem.103.1.1. View

10.

BARANDUN S, HUSER H, Hassig A . [Clinical forms of the antibody deficiency syndrome]. Schweiz Med Wochenschr. 1958; 88(4):78-82. View

11.

DUBOS R, Schaedler R . Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J Exp Med. 1956; 104(1):53-65. PMC: 2136634. DOI: 10.1084/jem.104.1.53. View

12.

BLATTBERG B . Increase in bactericidal activity as a result of injection of zymosan. Proc Soc Exp Biol Med. 1956; 92(4):745-8. DOI: 10.3181/00379727-92-22600. View

13.

Barlow J, Van Vunakis H, Levine L . Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements. J Immunol. 1958; 80(5):339-48. View

14.

DI CARLO F, FIORE J . On the composition of zymosan. Science. 1958; 127(3301):756-7. DOI: 10.1126/science.127.3301.756-a. View

15.

HINZ Jr C, JORDAN Jr W, PILLEMER L . The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1956; 35(5):453-7. PMC: 438830. DOI: 10.1172/JCI103296. View

16.

Keller H, ISLIKER H, AEBI H . [Turnover of properidine in rabbits]. Helv Physiol Pharmacol Acta. 1957; 15(2):C21-2. View

17.

Fritzsche W, Fischer H, SCHWICK G, SCHULTZE H . [Determination of properdin and complement factors]. Klin Wochenschr. 1958; 36(3):100-7. DOI: 10.1007/BF01500450. View

18.

Linder E . [The properdin system & its control by ionizing radiation]. Strahlentherapie. 1957; 103(1):91-7. View

19.

Koch F, SCHULTZE H, SCHWICK G . [Complement factors and properdin in a healthy infant during the first year of life]. Klin Wochenschr. 1958; 36(1):17-20. DOI: 10.1007/BF01491122. View

20.

ISLIKER H, Linder E . [Preparation of a bacteriocidic serum protein (properdin)]. Helv Physiol Pharmacol Acta. 1956; 14(2):C34-C35. View